Literature DB >> 31531777

Clinical relevance of colonization with antimicrobial-resistant bacteria (AMRB) and methicillin susceptible Staphylococcus aureus (MSSA) for mothers during pregnancy.

A H Dammeyer1, S Heinze2,3, A C Adler4, L Nasri5, L Schomacher2, M Zamfir2, K Heigl2, B Karlin6, M Franitza5, S Hörmansdorfer2, C Tuschak2, G Valenza2, U Ochmann3, C Herr2,3.   

Abstract

PURPOSE: The impact of colonization with antimicrobial-resistant bacteria (AMRB) and methicillin-sensitive Staphylococcus aureus (MSSA) of healthy pregnant women is not described in detail in Germany. In this study, we screened for MSSA and AMRB, especially for methicillin-resistant S. aureus (MRSA) as well as extended-spectrum beta-lactamase (ESBL)-producing E. coli. Potential risk factors for colonization with AMRB/MSSA and the potential effects of colonization with these on the obstetric population were investigated.
METHODS: From October 2013 until December 2015 pregnant women were screened before birth for colonization with AMRB/MSSA from the mammillae, nose, perianal and vaginal area. Before birth, the expectant mother was administered a standardized interview questionnaire by a trained interviewer. Data from the hospital admission records were also included.
RESULTS: Samples from 651 pregnant women were analyzed. Colonization with MSSA was detected in 14.3% (n = 93), AMRB in 3.5% [(n = 23); MRSA: n = 3/ESBL: n = 20]. Significantly more colonization of AMRB/MSSA could be detected in women who had previously given birth compared to women who were nulliparous (p < 0.05). MSSA colonization was significantly associated with self-reported respiratory diseases during pregnancy (p < 0.05), but AMRB/MSSA colonization was not statistically associated with other types of infection.
CONCLUSION: Our results demonstrate a low overall rate of colonization with AMRB/MSSA, as well as a low percentage of colonized pregnant women who developed infections. Multiparous women are at higher risk for colonization with MSSA/MRSA or ESBL. Because the prevalence of AMRB/MSSA is low, this study suggests that general screening of pregnant women without risk factors is not recommended.

Entities:  

Keywords:  AMR; AMRB; ESBL; MRSA; MSSA; Pregnancy; Prevalence; Risk factors

Year:  2019        PMID: 31531777     DOI: 10.1007/s00404-019-05287-6

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  4 in total

1.  Vancomycin Pharmacokinetics in a Pregnancy Rat Model.

Authors:  Sean N Avedissian; Gwendolyn M Pais; Michelle Pham; Jiajun Liu; Jack Chang; Khrystyna Hlukhenka; Walter Prozialeck; Brooke Griffin; Anil Gulati; Medha D Joshi; Ying Mu; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2022-04-21       Impact factor: 5.938

2.  Vaginal colonization with antimicrobial-resistant bacteria among women in labor in central Uganda: prevalence and associated factors.

Authors:  Josephine Tumuhamye; Hans Steinsland; Freddie Bwanga; James K Tumwine; Grace Ndeezi; David Mukunya; Olive Namugga; Agnes Napyo Kasede; Halvor Sommerfelt; Victoria Nankabirwa
Journal:  Antimicrob Resist Infect Control       Date:  2021-02-17       Impact factor: 4.887

3.  Rising prevalence of multidrug-resistant uropathogenic bacteria from urinary tract infections in pregnant women.

Authors:  Umema Asmat; Muhammad Z Mumtaz; Arif Malik
Journal:  J Taibah Univ Med Sci       Date:  2020-11-11

4.  Characterization of aerobic vaginitis in late pregnancy in a Chinese population: A STROBE-compliant study.

Authors:  Yuanting Tang; Fan Yu; Zhengqiang Hu; Luyun Peng; Yongmei Jiang
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.